Prednisone Recruiting Phase 3 Trials for Dapsone / Adult Immune Thrombocytopenia (ITP) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02627417Efficacy and Safety of DAPSone as a Second-line Option in Adult Immune Thrombocytopenia